Author: Aran Singanayagam; Joseph Footitt; Benjamin T Kasdorf; Matthias Marczynski; Michael T Cross; Lydia J Finney; Maria-Belen Trujillo Torralbo; Maria Calderazzo; Jie Zhu; Julia Aniscenko; Thomas B Clarke; Philip L Molyneaux; Nathan W Bartlett; Miriam F Moffatt; William O Cookson; Jadwiga Wedzicha; Christopher M Evans; Oliver Lieleg; Patrick Mallia; Sebastian L Johnston
Title: MUC5AC drives COPD exacerbation severity through amplification of virus-induced airway inflammation Document date: 2019_7_22
ID: gg2ctmn7_34
Snippet: Given our prior observations that Muc5ac deletion was anti-inflammatory, while augmentation with exogenous MUC5AC protein in mice had broad pro-inflammatory effects, we reasoned that this mucin could be mediating its effects via a danger signal that promotes inflammatory mediator release and cell recruitment. A previous study demonstrated that supernatants of mucopurulent material from subjects with cystic fibrosis can induce epithelial release o.....
Document: Given our prior observations that Muc5ac deletion was anti-inflammatory, while augmentation with exogenous MUC5AC protein in mice had broad pro-inflammatory effects, we reasoned that this mucin could be mediating its effects via a danger signal that promotes inflammatory mediator release and cell recruitment. A previous study demonstrated that supernatants of mucopurulent material from subjects with cystic fibrosis can induce epithelial release of extracellular adenosine triphosphate (ATP) 20 , a well-recognised promoter of inflammation 21 that is also virus-inducible 22 . We therefore hypothesised that MUC5AC exerts its pro-inflammatory effects during RV infection via induction of extracellular ATP and examined the effect of ATP neutralisation using the ATP-hydrolysing enzyme apyrase in exogenous MUC5AC-treated RV-infected mice (Fig 5a) . Exogenous MUC5AC protein administration augmented BAL concentrations of ATP in RV-infected mice, an effect that was abrogated by instillation of apyrase (Fig 5b) . Apyrase administration also suppressed exogenous MUC5AC-mediated increases in airway inflammation during RV infection including BAL total cells and neutrophils (Fig. 5c) , inflammatory chemokines CXCL1/KC, CXCL2/MIP-2 and CCL5/RANTES (Fig. 5d) and pro-inflammatory cytokines TNF and IL-1b (Fig. 5e) . Apyrase also prevented the exogenous MUC5AC-mediated increase in neutrophil elastase, reversed the MUC5AC-mediated suppression of SLPI and suppressed MUC5ACmediated increased bacterial loads in RV-infected mice (Fig 5f-g) . Apyrase-mediated reversal of pro-inflammatory effects of MUC5AC did not occur via interference with antiviral immune responses or virus control, as we also observed no effect of apyrase on RVinduction of IFN-α, IFN-l2/3 (Supplementary Fig.6a -c) or lung virus loads ( Supplementary Fig.6d) .
Search related documents:
Co phrase search for related documents- cell recruitment and epithelial release: 1
- cell recruitment and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- immune response and inflammatory mediator: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- immune response and inflammatory mediator release: 1, 2
- immune response and lung virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immune response and lung virus load: 1
- immune response and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- immune response and pro inflammatory cytokine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immune response and pro inflammatory effect: 1, 2, 3, 4, 5, 6, 7, 8
- immune response and rv infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- immune response and total cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- immune response and virus control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- inflammatory mediator and lung virus: 1, 2
- inflammatory mediator and pro inflammatory cytokine: 1, 2, 3, 4
- inflammatory mediator and pro inflammatory effect: 1
- previous study and pro inflammatory cytokine: 1, 2, 3, 4, 5, 6
- previous study and rv infection: 1, 2, 3, 4, 5, 6
- previous study and total cell: 1, 2, 3
- previous study and virus control: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date